Skip to main content

SYSTEMATIC REVIEW article

Front. Nutr.
Sec. Nutrition, Psychology and Brain Health
Volume 11 - 2024 | doi: 10.3389/fnut.2024.1497569
This article is part of the Research Topic Culinary Medicine and its Influence on Human Health View all 5 articles

Relevance of Diet in Schizophrenia: A Review Focusing on Prenatal Nutritional Deficiency, Obesity, Oxidative Stress and Inflammation

Provisionally accepted
Viorica Rarinca Viorica Rarinca 1,2*Amalia Vasile Amalia Vasile 1*Malina Visternicu Malina Visternicu 1,2Vasile Burlui Vasile Burlui 2*Gabriela Halitchi Gabriela Halitchi 2*Alin Ciobica Alin Ciobica 1,2,3Ana Maria Singeap Ana Maria Singeap 4,5*Romeo Dobrin Romeo Dobrin 4,6*Ecaterina Burlui Ecaterina Burlui 2*Lucian Maftei Lucian Maftei 7*Anca Trifan Anca Trifan 4,8
  • 1 Alexandru Ioan Cuza University, Iași, Romania
  • 2 Apollonia University, Iași, Romania
  • 3 Romanian Academy, Iasi Branch, Iași, Romania
  • 4 Grigore T. Popa University of Medicine and Pharmacy, Iași, Iasi, Romania
  • 5 Emergency County Hospital Saint Spiridon, Iasi, Romania
  • 6 Socola Iași Institute of Psychiatry, Iași, Romania
  • 7 SC MAKEUP SHOP SRL – Cosmetic product development department (Mihail Kogalniceanu Street, no. 2, Miroslava, Iasi, Romania, 707305), Iași, Romania
  • 8 Saint Spiridon Hospital, Iasi, Romania

The final, formatted version of the article will be published soon.

    Schizophrenia is a complex mental disorder influenced by genetic and environmental factors, including dietary habits. Oxidative stress and inflammation play a crucial role in the pathophysiology of schizophrenia. Emerging research suggests that diet may impact schizophrenia through various biological mechanisms beyond oxidative stress and inflammation. Notably, epigenetic changes can modify gene expression related to neurodevelopment and neurotransmitter systems, while neuroplasticity plays a crucial role in brain adaptation and resilience against psychiatric disorders. Nutritional deficiencies, such as lack of omega-3 fatty acids, vitamin D, and B vitamins, during prenatal and postnatal periods can negatively impact neurodevelopment and increase the risk of schizophrenia. Patients with schizophrenia show imbalances in antioxidant enzymes such as: glutathione peroxidase (GPx), superoxide dismutase (SOD), catalase (CAT), and reduced levels of antioxidants (vitamin E, vitamin C),. These biochemical alterations lead ing to heightened increased oxidative stress markers, including such as malondialdehyde (MDA). Furthermore, Ccytokine-mediated inflammation, microglial activation, and gut dysbiosis are associated with schizophrenia onset and severity of schizophrenia symptoms severity. Currently, Tthere is no clear and universally accepted dietary regimen for the treatmentmanaging of schizophrenia, which is considered the most popular. However, various diets and nutritional methods are being researched and applied to alleviate the symptoms of schizophrenia and improve the general health of patients, including the Mmediterranean diet, ketogenic diet, gluten-free diet, and dietary approaches to stop hypertension (DASH) diet. A healthy diet rich in anti-inflammatory and antioxidant nutrients can help manage schizophrenia by reducing oxidative stress, preventing complications, and improving quality of life. Omega-3 fatty acids, vitamin D and B vitamins are particularly important for brain development and function. In this review, we will focus on the influence of diet on schizophrenia.

    Keywords: Schizophrenia, Diet, Nutrients, Obesity, Oxidative Stress, Inflammation, Antioxidants, Prenatal Nutritional Deficiency Justified

    Received: 21 Sep 2024; Accepted: 29 Nov 2024.

    Copyright: © 2024 Rarinca, Vasile, Visternicu, Burlui, Halitchi, Ciobica, Singeap, Dobrin, Burlui, Maftei and Trifan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Viorica Rarinca, Alexandru Ioan Cuza University, Iași, Romania
    Amalia Vasile, Alexandru Ioan Cuza University, Iași, Romania
    Vasile Burlui, Apollonia University, Iași, 700399, Romania
    Gabriela Halitchi, Apollonia University, Iași, 700399, Romania
    Ana Maria Singeap, Grigore T. Popa University of Medicine and Pharmacy, Iași, 700115, Iasi, Romania
    Romeo Dobrin, Socola Iași Institute of Psychiatry, Iași, 700282, Romania
    Ecaterina Burlui, Apollonia University, Iași, 700399, Romania
    Lucian Maftei, SC MAKEUP SHOP SRL – Cosmetic product development department (Mihail Kogalniceanu Street, no. 2, Miroslava, Iasi, Romania, 707305), Iași, Romania

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.